Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea
· Delayed Price · Currency is KRW 80,000
-2,100 (-2.56%)
At close: Dec 5, 2025
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 6.66 trillion as of December 5, 2025. Its market cap has increased by 405.61% in one year.
Market Cap
6.66T
Enterprise Value
6.62T
Revenue
5.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
80,000.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 6.66T, an increase of 158.23%. That is a compound annual growth rate of 12.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.67T |
| Yuhan | 8,836.80B |
| LigaChem Biosciences | 7,139.05B |
| Peptron | 6,540.52B |